Phase II Study of Vinorelbine and Docetaxel in the Treatment of Advanced Non–Small-Cell Lung Cancer as Frontline and Second-Line Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase II Study of Vinorelbine and Docetaxel in the Treatment of Advanced Non–Small-Cell Lung Cancer as Frontline and Second-Line Therapy

Published:2010-04 Issue:2 Volume:33 Page:148-152
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

William William N.,Khuri Fadlo R.,Fossella Frank V.,Glisson Bonnie S.,Zinner Ralph G.,Lee J Jack,Herbst Roy S.,Lippman Scott M.,Kim Edward S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference27 articles.

1. Comparison of four chemotherapy regimens for advanced non–small-cell lung cancer.;Schiller;N Engl J Med,2002

2. Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non–small-cell lung cancer: the TAX 326 study group.;Fossella;J Clin Oncol,2003

3. Single agent versus combination chemotherapy in patients with advanced non–small-cell lung carcinoma: a meta-analysis of response, toxicity, and survival.;Lilenbaum;Cancer,1998

4. Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non–small-cell lung cancer–a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non–small-cell lung cancer.;Anderson;Br J Cancer,2000

5. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non–small-cell lung cancer. The Elderly Lung Cancer Vinorelbine Italian Study Group.;J Natl Cancer Inst,1999

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First and Second Line Chemotherapeutic Regimens for Non-Small Cell Lung Carcinomas - The Efficacy of Platinum, Non-Platinum and Combination Therapy: A Literature Review;Cureus;2020-11-22

2. Necitumumab: a new option for first-line treatment of squamous cell lung cancer;Expert Opinion on Drug Metabolism & Toxicology;2018-07-31

3. Incremental Innovation and Progress in Advanced Squamous Cell Lung Cancer: Current Status and Future Impact of Treatment;Journal of Thoracic Oncology;2016-12

4. Pemertrexed combined with cisplatin in the treatment of advanced non-small cell lung cancer: a case report and literature review;The Chinese-German Journal of Clinical Oncology;2012-01

5. Management of dyspnea in advanced lung cancer: recent data and emerging concepts;Current Opinion in Supportive & Palliative Care;2010-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3